Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Plandai Biotechnology, Inc. (PLPL) Announces Buy Recommendation From Murphy Analytics

Today before the opening bell, Plandai Biotechnology announced that Murphy Analytics, LLC has initiated coverage and issued a buy recommendation with a twelve month price potential of $2.20 per share.

According to Murphy Analytics, the positive potential valuation reflects the current value of plantation holdings of Plandai, the global market for green tea and green tea extracts, the profit projections prepared by Plandai, and the trading value of companies within the industry.

Plandai CEO Roger Duffield commented, "Murphy Analytics has a great reputation and we're pleased to see recognition of the market potential for Plandai's technology. As we shift our focus towards production and marketing, we do so with the goal of maximizing shareholder value while also improving the health and welfare of millions of potential customers."

In the report, the Murphy Analytics analyst stated, in part, the following:

"With a near-term focus on food and beverage, wellness, cosmeceutical and nutraceuticals, Plandai has access to very large and growing global markets. With a longer term focus on pharmaceuticals, targeting malaria in particular, Plandai has a very attractive long-term opportunity to complement the Company's near-term target markets.

"The global tea market is estimated at over $50 billion while Vitamin Shoppe estimates the U.S. nutritional supplements industry alone is over $29 billion, and growing at 5.4% per year. Driven by increasingly educated consumers, with a heighted focus on living longer, feeling younger, living healthy and naturally, GNC now generates $1.2 billion online and through 6,300 retail stores, serving as a barometer of the magnitude of the market opportunity.

"Positive industry trends include an aging U.S. population, rising healthcare costs and the increased use of preventive measures. In addition, the increased focus on diet and nutrition, along with growing fitness and wellness program participation, serves as a positive trend for the nutritional supplements industry."

Investors can view the 26-page report at the following link:

Please see disclaimer on the QualityStocks website: